What is the recommended dose schedule for carbimazole (antithyroid medication) per day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Carbimazole Dosing Schedule

For hyperthyroidism treatment, carbimazole should be administered as a single daily dose of 20-40 mg once daily, with 20 mg being preferred for mild-to-moderate disease and 40 mg reserved for severe hyperthyroidism, taken at any time of day (typically at bedtime for convenience). 1, 2

Standard Dosing Regimens

Initial Dose Selection

  • 20 mg once daily is the recommended starting dose for patients with mild-to-moderate hyperthyroidism (baseline total T4 ≤260 nmol/L), as this dose effectively controls hyperthyroidism while minimizing the risk of iatrogenic hypothyroidism 1

  • 40 mg once daily should be used for patients with severe hyperthyroidism (baseline total T4 >260 nmol/L), as lower doses are less effective at controlling severe disease 1

  • 30 mg once daily represents a middle-ground option that has been validated in multiple studies and achieves euthyroidism in 1-3 months for most patients 2, 3

Timing and Administration

  • Single daily dosing is as effective as divided doses (three times daily) because carbimazole has a long intrathyroidal half-life despite a short plasma half-life 3, 4

  • Bedtime administration is commonly recommended for convenience and improved compliance, though the drug can be taken at any time of day 3

  • Propranolol 20 mg three times daily should be co-administered for the first 3-4 weeks to control adrenergic symptoms 2, 4

Monitoring and Dose Adjustment

  • Thyroid function tests (total T4, total T3, TSH) should be checked at baseline, then at 4 weeks and 10 weeks after starting therapy 1

  • Patients on 20 mg daily typically achieve euthyroidism in 4-6 weeks, while those on 40 mg daily achieve biochemical control faster (by 4 weeks) but have higher risk of iatrogenic hypothyroidism 1

  • The 40 mg dose produces significantly lower thyroid hormone levels at 4 weeks (free T4: 19.4 vs 35.2 pmol/L; free T3: 8.3 vs 13.7 pmol/L) compared to 20 mg, but clinical symptoms improve similarly by 6-12 weeks 1

Duration of Therapy

  • Treatment should continue until TSH response to TRH normalizes, typically 9-41 weeks (median 18 weeks) 2

  • Stopping carbimazole when T3 and T4 are in the low-normal range (usually 2-4 months after clinical euthyroidism) may improve remission rates 2

Important Caveats

Drug Resistance

  • Rarely, patients may not respond to standard or even supratherapeutic doses of carbimazole (up to 60 mg daily) 5

  • If no biochemical improvement occurs after 4 months of compliant therapy, consider carbimazole resistance and switch to propylthiouracil 150 mg three times daily or proceed to definitive therapy (radioiodine ablation or thyroidectomy) 5

  • Always verify medication compliance through supervised administration before diagnosing drug resistance 5

Predictors of Response

  • Patients with large goiters and elevated alkaline phosphatase take longer to respond to therapy 2

  • Severe hyperthyroidism (T4 >260 nmol/L) requires the higher 40 mg dose for adequate control 1

Pregnancy Considerations

  • In pregnant women with hyperthyroidism, thioamides (propylthiouracil or methimazole/carbimazole) should be used at the lowest possible dose to maintain free T4 in the high-normal range, with monitoring every 2-4 weeks 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.